R. Otter

6.4k total citations · 1 hit paper
58 papers, 2.7k citations indexed

About

R. Otter is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, R. Otter has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 16 papers in Public Health, Environmental and Occupational Health and 11 papers in Cancer Research. Recurrent topics in R. Otter's work include Global Cancer Incidence and Screening (12 papers), Breast Cancer Treatment Studies (11 papers) and Palliative Care and End-of-Life Issues (8 papers). R. Otter is often cited by papers focused on Global Cancer Incidence and Screening (12 papers), Breast Cancer Treatment Studies (11 papers) and Palliative Care and End-of-Life Issues (8 papers). R. Otter collaborates with scholars based in Netherlands, Italy and United Kingdom. R. Otter's co-authors include Michael Schaapveld, Pax H.B. Willemse, Elisabeth G.E. de Vries, J.W.W. Coebergh, Flora E. van Leeuwen, Sabine Siesling, Jan Maarten van der Zwan, Winette T.A. van der Graaf, Angelo Paolo Dei Tos and Annalisa Trama and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

R. Otter

56 papers receiving 2.6k citations

Hit Papers

Rare cancers are not so rare: The rare cancer burden in E... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rare cancers are not so rare: The rare cancer burden in Europe
    2011 500 citations Gemma Gatta, Jan Maarten van der Zwan et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Otter Netherlands 26 1.2k 552 511 506 452 58 2.7k
Russell B. McBride United States 30 1.5k 1.3× 321 0.6× 624 1.2× 595 1.2× 790 1.7× 80 3.4k
Michaela A. Dinan United States 31 969 0.8× 525 1.0× 427 0.8× 536 1.1× 938 2.1× 118 3.3k
Kangmin Zhu United States 32 1.9k 1.6× 418 0.8× 468 0.9× 1.1k 2.1× 695 1.5× 151 4.0k
Bryan Fellman United States 29 955 0.8× 203 0.4× 320 0.6× 595 1.2× 589 1.3× 188 2.8k
Gianfilippo Bertelli United Kingdom 27 1.3k 1.1× 421 0.8× 563 1.1× 364 0.7× 244 0.5× 107 2.2k
Helgi Sigvaldason Iceland 32 688 0.6× 695 1.3× 359 0.7× 374 0.7× 599 1.3× 82 3.3k
Claire Falandry France 26 1.2k 1.0× 162 0.3× 244 0.5× 582 1.2× 477 1.1× 109 3.1k
H. Anderson Sweden 28 1.4k 1.2× 482 0.9× 582 1.1× 603 1.2× 333 0.7× 51 2.8k
Åsa Klint Sweden 26 1.1k 0.9× 195 0.4× 211 0.4× 464 0.9× 360 0.8× 34 2.3k
Victor R. Grann United States 37 2.7k 2.2× 1.2k 2.2× 1.0k 2.0× 759 1.5× 603 1.3× 66 5.0k

Countries citing papers authored by R. Otter

Since Specialization
Citations

This map shows the geographic impact of R. Otter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Otter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Otter more than expected).

Fields of papers citing papers by R. Otter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Otter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Otter. The network helps show where R. Otter may publish in the future.

Co-authorship network of co-authors of R. Otter

This figure shows the co-authorship network connecting the top 25 collaborators of R. Otter. A scholar is included among the top collaborators of R. Otter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Otter. R. Otter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyaga, Victoria Nyawira, et al.. (2019). The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer. Archives of Public Health. 77(1). 15–15. 2 indexed citations
2.
3.
Zwan, Jan Maarten van der, Annalisa Trama, R. Otter, et al.. (2013). Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project. European Journal of Cancer. 49(11). 2565–2578. 87 indexed citations
4.
Zwan, Jan Maarten van der, Sandra Mallone, Boukje A. C. van Dijk, et al.. (2012). Carcinoma of endocrine organs: Results of the RARECARE project. European Journal of Cancer. 48(13). 1923–1931. 40 indexed citations
5.
6.
Gatta, Gemma, Jan Maarten van der Zwan, Paolo G. Casali, et al.. (2011). Rare cancers are not so rare: The rare cancer burden in Europe. European Journal of Cancer. 47(17). 2493–2511. 500 indexed citations breakdown →
7.
8.
Schaapveld, Michael, Otto Visser, Marieke W.J. Louwman, et al.. (2008). Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study. Journal of Clinical Oncology. 26(8). 1239–1246. 167 indexed citations
9.
Finlay, Ilora, et al.. (2007). The New Millennium Palliative Care Project (2000-2003): the impact of specialised GP advisors.. PubMed Central. 57(539). 494–6. 6 indexed citations
10.
Engelen, M.J.A., Pax H.B. Willemse, Jan G. Aalders, et al.. (2005). Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer. 106(3). 589–598. 234 indexed citations
11.
Schaapveld, Michael, et al.. (2005). Soft tissue sarcoma: why not treated?. Critical Reviews in Oncology/Hematology. 54(1). 77–83. 9 indexed citations
12.
Meijler, Willem J., et al.. (2005). Educational Needs of General Practitioners in Palliative Care: Outcome of a Focus Group Study. Journal of Cancer Education. 20(1). 28–33. 30 indexed citations
13.
Schaapveld, Michael, R. Otter, Elisabeth G.E. de Vries, et al.. (2004). Variability in axillary lymph node dissection for breast cancer. Journal of Surgical Oncology. 87(1). 4–12. 55 indexed citations
14.
Mulder, Nanno H., et al.. (2001). Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer (Br J Surg 2001; 88 : 101-6) - Reply. British journal of surgery. 88(8). 1129–1129. 6 indexed citations
15.
Otter, R., et al.. (2000). The effects of a postgraduate course on opioid-prescribing patterns of general practitioners.. PubMed. 15(4). 214–7. 11 indexed citations
16.
Eland, Ingo A., et al.. (1998). [Provision of taxoids in 1996: inequality of care].. PubMed. 142(10). 518–21. 2 indexed citations
17.
Visscher, Jan G.A.M. de, Michael Schaapveld, R. Otter, Otto Visser, & I. van der Waal. (1998). Epidemiology of cancer of the lip in the Netherlands. Oral Oncology. 34(5). 421–426. 38 indexed citations
18.
Sleijfer, Dirk Th., et al.. (1998). Symptoms and Functional Status of Patients With Disseminated Cancer Visiting Outpatient Departments. Journal of Pain and Symptom Management. 16(5). 290–297. 50 indexed citations
19.
Scaf-Klomp, W, Robbert Sanderman, H.B.M. van de Wiel, R. Otter, & Wim JA van den Heuvel. (1997). Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands.. Journal of Epidemiology & Community Health. 51(6). 705–710. 69 indexed citations
20.
Leeuwen, Flora E. van, Alexandra W. van den Belt‐Dusebout, J. Benraadt, et al.. (1994). Risk of endometrial cancer after tamoxifen treatment of breast cancer. The Lancet. 343(8895). 448–452. 455 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell B. McBride Breakdown of academic impact, for papers by Michaela A. Dinan Breakdown of academic impact, for papers by Kangmin Zhu Breakdown of academic impact, for papers by Bryan Fellman Breakdown of academic impact, for papers by Gianfilippo Bertelli Breakdown of academic impact, for papers by Helgi Sigvaldason Breakdown of academic impact, for papers by Claire Falandry Breakdown of academic impact, for papers by H. Anderson Breakdown of academic impact, for papers by Åsa Klint Breakdown of academic impact, for papers by Victor R. Grann
Rankless by CCL
2026